These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 8883711)

  • 21. 111In-pentetreotide scintigraphy is superior to 123I-MIBG scintigraphy in the diagnosis and location of chemodectoma.
    Muros MA; Llamas-Elvira JM; Rodríguez A; Ramírez A; Gómez M; Arráez MA; Valéncia E; Vílchez R
    Nucl Med Commun; 1998 Aug; 19(8):735-42. PubMed ID: 9751927
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Safety and Efficacy of 68Ga-DOTATATE PET/CT for Diagnosis, Staging, and Treatment Management of Neuroendocrine Tumors.
    Deppen SA; Liu E; Blume JD; Clanton J; Shi C; Jones-Jackson LB; Lakhani V; Baum RP; Berlin J; Smith GT; Graham M; Sandler MP; Delbeke D; Walker RC
    J Nucl Med; 2016 May; 57(5):708-14. PubMed ID: 26769865
    [TBL] [Abstract][Full Text] [Related]  

  • 23. In-111 pentetreotide scintigraphy in patients with neuroblastoma. Comparison with I-131 MIBG, N-Myc oncogene amplification, and patient outcome.
    Shalaby-Rana E; Majd M; Andrich MP; Movassaghi N
    Clin Nucl Med; 1997 May; 22(5):315-9. PubMed ID: 9152532
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Indium-111 pentetreotide uptake by pancreatic polypeptide cell hyperplasia: potential pitfall in somatostatin receptor scintigraphy.
    Bunning J; Merchant SH; Crooks LA; Hartshorne MF
    Pancreas; 2007 Nov; 35(4):372-5. PubMed ID: 18090246
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Somatostatin receptor scintigraphy with 111In-pentetreotide in non-functioning gastroenteropancreatic neuroendocrine tumors.
    Schillaci O; Spanu A; Scopinaro F; Falchi A; Corleto V; Danieli R; Marongiu P; Pisu N; Madeddu G; Delle Fave G; Madeddu G
    Int J Oncol; 2003 Dec; 23(6):1687-95. PubMed ID: 14612942
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Relative quantification of indium-111 pentetreotide and gallium-68 DOTATOC uptake in the thyroid gland and association with thyroid pathologies.
    Lincke T; Singer J; Kluge R; Sabri O; Paschke R
    Thyroid; 2009 Apr; 19(4):381-9. PubMed ID: 19355828
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effective treatment of bone metastases from a neuroendocrine tumour of the pancreas with high activities of Indium-111-pentetreotide.
    van der Hiel B; Stokkel MP; Chiti A; Lucignani G; Bajetta E; Pauwels EK; Bombardieri E
    Eur J Endocrinol; 2003 Dec; 149(6):479-83. PubMed ID: 14640987
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Comparison of metabolic and receptor imaging in recurrent medullary thyroid carcinoma with histopathological findings.
    Adams S; Baum RP; Hertel A; Schumm-Draeger PM; Usadel KH; Hör G
    Eur J Nucl Med; 1998 Sep; 25(9):1277-83. PubMed ID: 9724377
    [TBL] [Abstract][Full Text] [Related]  

  • 29. In-111 pentetreotide. Superior imaging agent for gastrinomas.
    McCown JS; Gordon L; Uflacker RP
    Clin Nucl Med; 1995 Oct; 20(10):896-8. PubMed ID: 8616995
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Improved visualization of carcinoid liver metastases by indium-111 pentetreotide scintigraphy following treatment with cold somatostatin analogue.
    Dörr U; Räth U; Sautter-Bihl ML; Guzman G; Bach D; Adrian HJ; Bihl H
    Eur J Nucl Med; 1993 May; 20(5):431-3. PubMed ID: 8100192
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Dual-phase helical CT of nonfunctioning islet cell tumors.
    Stafford Johnson DB; Francis IR; Eckhauser FE; Knol JA; Chang AE
    J Comput Assist Tomogr; 1998; 22(1):59-63. PubMed ID: 9448762
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Metastatic carcinoid tumor imaged with CT and a radiolabeled somatostatin analog: a case report.
    Lobrano MB; McCarthy K; Adams L; Neitzschman H
    Am J Gastroenterol; 1997 Mar; 92(3):513-5. PubMed ID: 9068482
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Imaging of somatostatin receptor using 111In-pentetreotide].
    Kimura T; Sakahara H; Higashi T; Honda T; Konishi J; Hosotani R; Oshio G; Imamura M; Inokuma T
    Kaku Igaku; 1996 Apr; 33(4):447-52. PubMed ID: 8683886
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Indium-111-DTPA-phenyl-pentetreotide somatostatin receptors' scintigraphy in the evaluation of patients with suspected gastro-entero-pancreatic tumors. Comparison with computerized tomography].
    Gerasimou GP; Aggelopoulou T; Papanastasiou E; Konidari-Dedousi E; Prousalidis I; Psarrakos K; Siountas A; Molybda E; Gotzamani-Psarrakou A
    Hell J Nucl Med; 2007; 10(3):209-14. PubMed ID: 18084669
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Comparison of somatostatin receptor imaging, computed tomography and ultrasound in the clinical management of neuroendocrine gastro-entero-pancreatic tumours.
    Chiti A; Fanti S; Savelli G; Romeo A; Bellanova B; Rodari M; van Graafeiland BJ; Monetti N; Bombardieri E
    Eur J Nucl Med; 1998 Oct; 25(10):1396-403. PubMed ID: 9818279
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Somatostatin-receptor imaging of neuroendocrine gastroenteropancreatic tumors.
    Scherübl H; Bäder M; Fett U; Hamm B; Schmidt-Gayk H; Koppenhagen K; Dop FJ; Riecken EO; Wiedenmann B
    Gastroenterology; 1993 Dec; 105(6):1705-9. PubMed ID: 7902821
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Laparoscopic resection of a pancreatic polypeptidoma with a solitary liver metastasis.
    Chan WF; Lo CY; Lo CM; Fan ST
    Surg Endosc; 2004 Mar; 18(3):554-6. PubMed ID: 15115015
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Dynamic indium-111-pentetreotide scintigraphy in breast cancer.
    Bajc M; Ingvar C; Palmer J
    J Nucl Med; 1996 Apr; 37(4):622-6. PubMed ID: 8691252
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Indium-111-pentetreotide imaging in intra-axial brain tumors: comparison with thallium-201 SPECT and MRI.
    Lee JD; Kim DI; Lee JT; Chang JW; Park CY
    J Nucl Med; 1995 Apr; 36(4):537-41. PubMed ID: 7699438
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Clinical impact of somatostatin receptor scintigraphy in the management of patients with neuroendocrine gastroenteropancreatic tumors.
    Lebtahi R; Cadiot G; Sarda L; Daou D; Faraggi M; Petegnief Y; Mignon M; le Guludec D
    J Nucl Med; 1997 Jun; 38(6):853-8. PubMed ID: 9189129
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.